Understanding this molecular pathway will facilitate the search for new active compounds that could interact with CXCL17 of some of the proteins that directly or indirectly affects the metastatic properties of lung adenocarcinomas. This evidence concerns the gene CXCL17 and lung adenocarcinoma.